(Millipore). Cell lysates were clarified by centrifugation at 23,000 × g for 30 min at 4°C, 215 and the protein concentration in the supernatant fraction was quantified using the 216 Bradford protein assay (Bioshop). Proteins were resolved by 10% SDS-PAGE and 217 electrotransferred onto polyvinylidene fluoride membrane (PVDF) (Millipore) in 218 transfer buffer (10 mM CAPS, pH 11.0, 10% methanol). The membranes were blocked 219 with 5% nonfat dry milk/TBST (blocking buffer) for 1 h at room temperature and then 220 incubated overnight at 4°C with diluted primary antibodies in blocking buffer. The 221 specific primary antibodies against Bcl-2, cleaved caspase-8, cleaved caspase-9, 222 cleaved caspase-3 (Cell Signaling), Bax (Santa Cruz), Cdc2, cyclin B1, cleaved PARP 223 and β-actin (GeneTex) were used. After washing with TBST, the membranes were 224 incubated with HRP-conjugated anti-goat (GeneTex) or anti-rabbit (Jackson 225 Immunoresearch) secondary antibody. Chemiluminescence was detected using 226
WesternBright ECL western blotting reagent (Advansta). 227
Statistical analysis

228
The results were presented as mean ± standard deviation (SD). Statistical analysis using 229 one-way analysis of variance (ANOVA) performed with SigmaPlot software. The 230 results were considered to be statistically significant when p-values were less than 0.05. 231
Each experiment was done in triplicate. 232 When the TC-HT was combined with either of the two compounds, a significant 248 dose-dependent decrease in viability was observed at all four cycling parameters. 249
233
Results
234
TC-HT in combination with polyphenols synergistically
Although the 1-cycle TC-HT and either the compound cooperatively reduced the 250 proliferation of PANC-1 cells, the heat alone resulted in significant cytotoxicity to the 251 cells. Notably, there was no difference in the cell viability under the condition of the 252 10-cycles TC-HT when compared to that in the control group, while it still was capable 253 of working synergistically with either the CGA or the EGCG to exert the 254 anti-proliferative activity. The SQ values for the corresponding treatments are as shown 255
in Table 1 . This suggests that both the CGA and the EGCG could exhibit a synergistic 256 cytotoxic effect when co-administered with the TC-HT, particularly in the treatment of 257 10 cycles. We next performed a clonogenic survival assay to confirm the effect of the 258 TC-HT combined with CGA or EGCG on cell proliferation. As shown in and fragmented nuclei, which are typical morphological alterations for the apoptosis 320 (Fig 4C) . These results suggest that the TC-HT has a potential synergistic effect with 321 the CGA or EGCG on the apoptosis in the PANC-1 cells. 322 indicated that neither the TC-HT nor these two compounds induced significant 473 apoptotic cells (Fig 4) . Only when the TC-HT in combination with the CGA or 474 EGCG was conducted, both of the combined treatments significantly elevated the expression, and increased Bax expression. We also found that the activation of 487 caspase-9, -3, and the cleavage of PARP were promoted with both of the combined 488 treatments (Fig 6) . Collectively, these data indicated that the mitochondria-dependent 489 pathway is involved in the synergistic apoptosis following the combined treatments. 
